Literature DB >> 34166802

Increasing proportions of relapsing parasite species among imported malaria in China's Guangxi Province from Western and Central Africa.

Penglu Liu1, Lijie Shen1, Siqi Wang1, Pien Qin2, Yu Si1, Maohua Pan2, Weilin Zeng1, Yucheng Qin2, Xi Chen1, Yanmei Zhang1, Cuiying Li1, Zheng Xiang1, Lynette Menezes3, Yaming Huang4, Liwang Cui5, Zhaoqing Yang6.   

Abstract

BACKGROUND: Travel-related malaria in non-endemic areas returning from endemic areas presents important challenges to diagnosis and treatment. Imported malaria to newly malaria-free countries poses further threats of malaria re-introduction and potential resurgence. For those traveling to places with high Plasmodium falciparum prevalence, prophylaxis against this parasite is recommended, whereas causal prophylaxis against relapsing malaria is often overlooked.
METHODS: We analyzed a cluster of imported malaria among febrile patients in Shanglin County, Guangxi Province, China, who had recent travel histories to Western and Central Africa. Malaria was diagnosed by microscopy and subsequently confirmed by species- and subspecies-specific PCR. Plasmodium vivax was genotyped using a barcode consisting of 42 single nucleotide polymorphisms.
RESULTS: Investigations of 344 PCR-confirmed malaria cases revealed that in addition to Plasmodium falciparum being the major parasite species, the relapsing parasites Plasmodium ovale and P. vivax accounted for ~40% of these imported cases. Of the 114 P. ovale infections, 65.8% and 34.2% were P. ovale curtisi and P. ovale wallikeri, respectively, with the two subspecies having a ~2:1 ratio in both Western and Central Africa. Phylogenetic analysis of 14 P. vivax isolates using a genetic barcode demonstrated that 11 formed a distinct clade from P. vivax populations from Eastern Africa.
CONCLUSION: This study provides support for active P. vivax transmission in areas with the predominant Duffy-negative blood group. With relapsing malaria making a substantial proportion of the imported malaria, causal prophylaxis should be advocated to travelers with a travel destination to Western and Central Africa.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Central africa; Imported malaria; Plasmodium ovale; Plasmodium vivax; Relapses; West africa

Mesh:

Year:  2021        PMID: 34166802      PMCID: PMC8429216          DOI: 10.1016/j.tmaid.2021.102130

Source DB:  PubMed          Journal:  Travel Med Infect Dis        ISSN: 1477-8939            Impact factor:   20.441


  33 in total

Review 1.  Plasmodium vivax Infections of Duffy-Negative Erythrocytes: Historically Undetected or a Recent Adaptation?

Authors:  Karthigayan Gunalan; Amadou Niangaly; Mahamadou A Thera; Ogobara K Doumbo; Louis H Miller
Journal:  Trends Parasitol       Date:  2018-03-09

2.  Plasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy people.

Authors:  Didier Ménard; Céline Barnadas; Christiane Bouchier; Cara Henry-Halldin; Laurie R Gray; Arsène Ratsimbasoa; Vincent Thonier; Jean-François Carod; Olivier Domarle; Yves Colin; Olivier Bertrand; Julien Picot; Christopher L King; Brian T Grimberg; Odile Mercereau-Puijalon; Peter A Zimmerman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-15       Impact factor: 11.205

3.  Plasmodium vivax Infections in Duffy-Negative Individuals in the Democratic Republic of the Congo.

Authors:  Nicholas F Brazeau; Amy N Whitesell; Stephanie M Doctor; Corinna Keeler; Melchior Kashamuka Mwandagalirwa; Antoinette K Tshefu; Joris L Likwela; Jonathan J Juliano; Steven R Meshnick
Journal:  Am J Trop Med Hyg       Date:  2018-11       Impact factor: 2.345

4.  Transmission of Plasmodium vivax in Duffy-negative individuals in central Sudan.

Authors:  Mohamed H Abdelraheem; Musab M A Albsheer; Hiba S Mohamed; Mutaz Amin; Muzamil Mahdi Abdel Hamid
Journal:  Trans R Soc Trop Med Hyg       Date:  2016-04       Impact factor: 2.184

5.  Vivax malaria in Mauritania includes infection of a Duffy-negative individual.

Authors:  Nathalie Wurtz; Khadijetou Mint Lekweiry; Hervé Bogreau; Bruno Pradines; Christophe Rogier; Ali Ould Mohamed Salem Boukhary; Jamal Eddine Hafid; Mohamed Salem Ould Ahmedou Salem; Jean-François Trape; Leonardo K Basco; Sébastien Briolant
Journal:  Malar J       Date:  2011-11-03       Impact factor: 2.979

6.  Development of a single nucleotide polymorphism barcode to genotype Plasmodium vivax infections.

Authors:  Mary Lynn Baniecki; Aubrey L Faust; Stephen F Schaffner; Daniel J Park; Kevin Galinsky; Rachel F Daniels; Elizabeth Hamilton; Marcelo U Ferreira; Nadira D Karunaweera; David Serre; Peter A Zimmerman; Juliana M Sá; Thomas E Wellems; Lise Musset; Eric Legrand; Alexandre Melnikov; Daniel E Neafsey; Sarah K Volkman; Dyann F Wirth; Pardis C Sabeti
Journal:  PLoS Negl Trop Dis       Date:  2015-03-17

7.  Genome-wide diversity and differentiation in New World populations of the human malaria parasite Plasmodium vivax.

Authors:  Thais C de Oliveira; Priscila T Rodrigues; Maria José Menezes; Raquel M Gonçalves-Lopes; Melissa S Bastos; Nathália F Lima; Susana Barbosa; Alexandra L Gerber; Guilherme Loss de Morais; Luisa Berná; Jody Phelan; Carlos Robello; Ana Tereza R de Vasconcelos; João Marcelo P Alves; Marcelo U Ferreira
Journal:  PLoS Negl Trop Dis       Date:  2017-07-31

8.  Genetic Spatiotemporal Anatomy of Plasmodium vivax Malaria Episodes in Greece, 2009-2013.

Authors:  Gregory Spanakos; Georges Snounou; Danai Pervanidou; Michael Alifrangis; Anna Rosanas-Urgell; Agoritsa Baka; Maria Tseroni; Annita Vakali; Evdokia Vassalou; Eleni Patsoula; Herve Zeller; Wim Van Bortel; Christos Hadjichristodoulou
Journal:  Emerg Infect Dis       Date:  2018-03       Impact factor: 6.883

9.  Characterization of Plasmodium ovale spp. imported from Africa to Henan Province, China.

Authors:  Ruimin Zhou; Suhua Li; Yuling Zhao; Chengyun Yang; Ying Liu; Dan Qian; Hao Wang; Deling Lu; Hongwei Zhang
Journal:  Sci Rep       Date:  2019-02-18       Impact factor: 4.379

10.  Molecular evidence of Plasmodium vivax mono and mixed malaria parasite infections in Duffy-negative native Cameroonians.

Authors:  Huguette Gaelle Ngassa Mbenda; Aparup Das
Journal:  PLoS One       Date:  2014-08-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.